NASDAQ:DH
Definitive Healthcare
- Stock
Last Close
5.50
17/05 20:00
Market Cap
1.42B
Beta: -
Volume Today
678.71K
Avg: 923.65K
PE Ratio
−5.03
PFCF: 51.60
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 3.66M - | 8.86M 141.80% | ||||
average payables | 3.91M - | 5.16M 31.90% | 4.30M 16.62% | |||
average receivables | 29.06M - | 38.22M 31.51% | 51.07M 33.61% | |||
book value per share | 13.66 - | 9.50 30.46% | 9.42 0.88% | |||
capex per share | -0.02 - | -0.07 359.43% | -0.08 12.44% | |||
capex to depreciation | -0.02 - | -0.11 379.56% | -0.15 30.31% | |||
capex to operating cash flow | -0.06 - | -0.27 344.33% | -0.23 12.35% | |||
capex to revenue | -0.01 - | -0.04 243.59% | -0.04 7.69% | |||
cash per share | 0.28 - | 4.22 1,389.31% | 3.28 22.15% | |||
days of inventory on hand | 65.71 - | 88.94 35.36% | ||||
days payables outstanding | 67.83 - | 41.72 38.49% | 33.81 18.97% | |||
days sales outstanding | 102.14 - | 95.20 6.79% | 96.39 1.25% | |||
debt to assets | 0.26 - | 0.26 3.67% | 0.13 51.66% | 0.13 1.67% | ||
debt to equity | 0.36 - | 0.39 6.95% | 0.31 19.76% | 0.29 6.54% | ||
dividend yield | 0.00 - | 0.00 316.96% | 0.01 257.97% | |||
earnings yield | -0.02 - | -0.02 5.41% | -0.02 17.87% | -0.18 801.59% | ||
enterprise value | 430.73M - | 4.23B 881.08% | 2.40B 43.32% | 1.24B 48.22% | ||
enterprise value over ebitda | 86.40 - | 58.06 32.80% | 36.73 36.75% | |||
ev to operating cash flow | 182.01 - | 95.00 47.80% | 34.86 63.31% | |||
ev to sales | 35.72 - | 14.42 59.64% | 5.57 61.36% | |||
free cash flow per share | 0.25 - | 0.20 19.36% | 0.27 34.05% | 0.37 35.52% | ||
free cash flow yield | 0.01 - | 0.01 27.73% | 0.02 233.36% | 0.04 49.84% | ||
graham net net | -5.72 - | -2.06 64.01% | -2.50 21.46% | |||
graham number | 17.54 - | 11.94 31.97% | 6.83 42.79% | |||
income quality | -0.45 - | -0.41 9.31% | -1.60 288.43% | -0.14 91.10% | ||
intangibles to total assets | 0.98 - | 0.96 1.85% | 0.76 20.37% | 0.79 3.47% | 0 100% | |
interest coverage | -0.29 - | -0.72 147.14% | -2.75 280.60% | 211.55 7,792.16% | ||
interest debt per share | 5.69 - | 3.23 43.34% | 2.81 12.86% | |||
inventory turnover | 5.55 - | 4.10 26.12% | ||||
invested capital | 0.36 - | 0.39 6.95% | 0.31 19.76% | 0.29 6.54% | ||
market cap | 3.79B - | 2.51B 33.70% | 1.11B 55.76% | 1.12B 0.87% | ||
net current asset value | -468.81M - | -485.95M 3.66% | -161.17M 66.83% | -220.03M 36.52% | ||
net debt to ebitda | 8.94 - | -2.83 131.69% | 3.82 234.82% | |||
net income per share | -1.00 - | -0.67 33.45% | -0.22 66.97% | -1.79 715.45% | ||
operating cash flow per share | 0.27 - | 0.27 3.40% | 0.35 28.28% | 0.37 3.81% | ||
payables turnover | 5.38 - | 8.75 62.58% | 10.80 23.41% | |||
receivables turnover | 3.57 - | 3.83 7.29% | 3.79 1.24% | |||
research and ddevelopement to revenue | 0.09 - | 0.11 19.51% | 0.16 40.25% | 0.17 7.73% | ||
return on tangible assets | -1.19 - | -0.12 89.74% | -0.05 59.21% | |||
revenue per share | 1.35 - | 1.81 33.71% | 2.20 21.81% | 2.23 1.25% | ||
roe | -0.07 - | -0.07 4.31% | -0.02 66.68% | |||
roic | -0.01 - | -0.02 49.83% | -0.01 36.26% | |||
sales general and administrative to revenue | 0.11 - | 0.18 68.17% | 0.22 19.24% | 0.23 6.86% | ||
shareholders equity per share | 13.66 - | 9.50 30.46% | 9.42 0.88% | |||
stock based compensation to revenue | 0.01 - | 0.06 305.86% | 0.16 173.06% | 0.19 18.47% | ||
tangible asset value | -463.31M - | -476.12M 2.76% | -110.65M 76.76% | -186.60M 68.64% | ||
tangible book value per share | -5.44 - | -1.20 77.87% | -1.85 53.30% | |||
working capital | -33.81M - | -24.88M 26.42% | 333.76M 1,441.59% | 281.24M 15.74% |
All numbers in USD (except ratios and percentages)